Skip to content

Clinical trials

Phase 2 Recurrence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2 Clear all

892 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200111
200210
200311
200422
200529
200630
200736
200824
200940
201032
201130
201241
201331
201435
201534
201629
201731
201842
201934
202033
202142
202235
202338
202441
202551
202651

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed393
Terminated124
Unknown status118
Recruiting112
Not yet recruiting50
Active, not recruiting48
Withdrawn44
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center24
Fred Hutchinson Cancer Center20
Memorial Sloan Kettering Cancer Center20
Novartis Pharmaceuticals19
Sun Yat-sen University15
Celgene12
National Cancer Institute (NCI)10
Massachusetts General Hospital9
Amgen8
H. Lee Moffitt Cancer Center and Research Institute8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence892
Multiple Myeloma131
Lymphoma101
Lymphoma, Large B-Cell, Diffuse98
Leukemia, Myeloid, Acute89
Lymphoma, Non-Hodgkin83
Neoplasm Metastasis83
Hodgkin Disease75
Leukemia, Lymphocytic, Chronic, B-Cell75
Precursor Cell Lymphoblastic Leukemia-Lymphoma73

Trials

Showing 76 to 100 of 892. Each trial links to its page on Pharma Observatory.

792 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.